US Stock MarketDetailed Quotes

ATMS ARTEMIS THERAPEUTICS INC

Watchlist
  • 0.498000
  • 0.0000000.00%
15min DelayTrading May 25 16:00 ET
55.79MMarket Cap-83000P/E (TTM)

ARTEMIS THERAPEUTICS INC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
38.85%-96K
-39.78%-390K
64.66%-41K
12.54%-55.7K
-35.87%-136.3K
-15,800.00%-157K
-27,800.00%-279K
-2,220.00%-116K
-2,222.97%-63.69K
-3,443.70%-100.31K
Net income from continuing operations
-22.66%-249K
-311.85%-1.36M
-178.02%-506K
-550.23%-444.32K
-372.69%-201.68K
-463.89%-203K
-171.90%-329K
-180.00%-182K
-135.63%-68.33K
-611.12%-42.67K
Operating gains losses
---4K
---14K
---8K
---492
----
----
----
----
----
----
Depreciation and amortization
100.00%4K
433.33%16K
100.00%4K
376.32%4.69K
--5.31K
--2K
--3K
--2K
--984
----
Other non cash items
75.00%7K
69.23%22K
20.00%6K
68.40%6.01K
--5.99K
--4K
--13K
--5K
--3.57K
----
Change In working capital
5.00%42K
1,941.18%694K
474.58%339K
344,612.90%320.58K
90.39%-5.58K
21.21%40K
-67.92%34K
1.72%59K
-99.67%93
-1,261.86%-58.09K
-Change in receivables
126.09%6K
-6.67%-16K
1,166.67%32K
-1,144.17%-14.51K
48.57%-10.49K
-428.57%-23K
-250.00%-15K
0.00%-3K
-97.38%1.39K
58.39%-20.39K
-Change in inventory
--12K
136.49%27K
150.00%19K
100.68%140
--7.86K
--0
---74K
---38K
---20.72K
----
-Change in payables and accrued expense
-61.90%24K
470.25%690K
191.84%286K
1,625.08%335.01K
138.84%5.99K
231.58%63K
35.96%121K
66.10%98K
171.93%19.42K
-130.24%-15.42K
-Change in other current assets
120.00%1K
----
----
----
----
---5K
----
----
----
----
-Change in other current liabilities
-120.00%-1K
-450.00%-7K
0.00%2K
---54
-99.23%-13.95K
-28.57%5K
-71.43%2K
0.00%2K
--0
-333.33%-7K
Cash from discontinued investing activities
Operating cash flow
38.85%-96K
-39.78%-390K
64.66%-41K
12.54%-55.7K
-35.87%-136.3K
-15,800.00%-157K
-27,800.00%-279K
-2,220.00%-116K
-2,222.97%-63.69K
-3,443.70%-100.31K
Investing cash flow
Cash flow from continuing investing activities
0
3.70%-26K
0
25.12%-8.36K
-7.64K
-10K
-27K
1K
-11.17K
Net PPE purchase and sale
--0
3.70%-26K
--0
25.12%-8.36K
---7.64K
---10K
---27K
--1K
---11.17K
----
Cash from discontinued investing activities
Investing cash flow
--0
3.70%-26K
--0
25.12%-8.36K
---7.64K
---10K
---27K
--1K
---11.17K
----
Financing cash flow
Cash flow from continuing financing activities
1,053.85%150K
0
-98.12%11K
-100.34%-256
-121.00%-23.74K
13K
774K
586K
74.91K
113.09K
Net issuance payments of debt
1,053.85%150K
--0
-87.06%11K
-100.34%-256
-121.00%-23.74K
--13K
--273K
--85K
--74.91K
--113.09K
Net common stock issuance
----
--0
----
----
----
----
--501K
----
----
----
Cash from discontinued financing activities
Financing cash flow
1,053.85%150K
--0
-98.12%11K
-100.34%-256
-121.00%-23.74K
--13K
--774K
--586K
--74.91K
--113.09K
Net cash flow
Beginning cash position
-88.32%55K
15,600.00%471K
--85K
--149.4K
15,750.00%317K
47,000.00%471K
50.00%3K
--0
--0
0.00%2K
Current changes in cash
135.06%54K
-188.89%-416K
-106.37%-30K
-119,214.81%-64.32K
-4,036.11%-167.68K
-15,500.00%-154K
46,900.00%468K
9,520.00%471K
-98.20%54
---4.05K
End cash Position
-65.62%109K
-88.32%55K
-88.32%55K
--85K
--149.4K
15,750.00%317K
47,000.00%471K
47,000.00%471K
--0
--0
Free cash flow
42.51%-96K
-35.95%-416K
64.35%-41K
14.42%-64.07K
-22.87%-143.93K
-16,800.00%-167K
-30,500.00%-306K
-2,200.00%-115K
-2,595.23%-74.86K
-4,004.77%-117.14K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 38.85%-96K-39.78%-390K64.66%-41K12.54%-55.7K-35.87%-136.3K-15,800.00%-157K-27,800.00%-279K-2,220.00%-116K-2,222.97%-63.69K-3,443.70%-100.31K
Net income from continuing operations -22.66%-249K-311.85%-1.36M-178.02%-506K-550.23%-444.32K-372.69%-201.68K-463.89%-203K-171.90%-329K-180.00%-182K-135.63%-68.33K-611.12%-42.67K
Operating gains losses ---4K---14K---8K---492------------------------
Depreciation and amortization 100.00%4K433.33%16K100.00%4K376.32%4.69K--5.31K--2K--3K--2K--984----
Other non cash items 75.00%7K69.23%22K20.00%6K68.40%6.01K--5.99K--4K--13K--5K--3.57K----
Change In working capital 5.00%42K1,941.18%694K474.58%339K344,612.90%320.58K90.39%-5.58K21.21%40K-67.92%34K1.72%59K-99.67%93-1,261.86%-58.09K
-Change in receivables 126.09%6K-6.67%-16K1,166.67%32K-1,144.17%-14.51K48.57%-10.49K-428.57%-23K-250.00%-15K0.00%-3K-97.38%1.39K58.39%-20.39K
-Change in inventory --12K136.49%27K150.00%19K100.68%140--7.86K--0---74K---38K---20.72K----
-Change in payables and accrued expense -61.90%24K470.25%690K191.84%286K1,625.08%335.01K138.84%5.99K231.58%63K35.96%121K66.10%98K171.93%19.42K-130.24%-15.42K
-Change in other current assets 120.00%1K-------------------5K----------------
-Change in other current liabilities -120.00%-1K-450.00%-7K0.00%2K---54-99.23%-13.95K-28.57%5K-71.43%2K0.00%2K--0-333.33%-7K
Cash from discontinued investing activities
Operating cash flow 38.85%-96K-39.78%-390K64.66%-41K12.54%-55.7K-35.87%-136.3K-15,800.00%-157K-27,800.00%-279K-2,220.00%-116K-2,222.97%-63.69K-3,443.70%-100.31K
Investing cash flow
Cash flow from continuing investing activities 03.70%-26K025.12%-8.36K-7.64K-10K-27K1K-11.17K
Net PPE purchase and sale --03.70%-26K--025.12%-8.36K---7.64K---10K---27K--1K---11.17K----
Cash from discontinued investing activities
Investing cash flow --03.70%-26K--025.12%-8.36K---7.64K---10K---27K--1K---11.17K----
Financing cash flow
Cash flow from continuing financing activities 1,053.85%150K0-98.12%11K-100.34%-256-121.00%-23.74K13K774K586K74.91K113.09K
Net issuance payments of debt 1,053.85%150K--0-87.06%11K-100.34%-256-121.00%-23.74K--13K--273K--85K--74.91K--113.09K
Net common stock issuance ------0------------------501K------------
Cash from discontinued financing activities
Financing cash flow 1,053.85%150K--0-98.12%11K-100.34%-256-121.00%-23.74K--13K--774K--586K--74.91K--113.09K
Net cash flow
Beginning cash position -88.32%55K15,600.00%471K--85K--149.4K15,750.00%317K47,000.00%471K50.00%3K--0--00.00%2K
Current changes in cash 135.06%54K-188.89%-416K-106.37%-30K-119,214.81%-64.32K-4,036.11%-167.68K-15,500.00%-154K46,900.00%468K9,520.00%471K-98.20%54---4.05K
End cash Position -65.62%109K-88.32%55K-88.32%55K--85K--149.4K15,750.00%317K47,000.00%471K47,000.00%471K--0--0
Free cash flow 42.51%-96K-35.95%-416K64.35%-41K14.42%-64.07K-22.87%-143.93K-16,800.00%-167K-30,500.00%-306K-2,200.00%-115K-2,595.23%-74.86K-4,004.77%-117.14K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg